Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 1...
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
About this item
Full title
Author / Creator
Eggermont, Alexander M M, Prof , Chiarion-Sileni, Vanna, MD , Grob, Jean-Jacques, Prof , Dummer, Reinhard, Prof , Wolchok, Jedd D, MD , Schmidt, Henrik, MD , Hamid, Omid, MD , Robert, Caroline, Prof , Ascierto, Paolo A, Prof , Richards, Jon M, MD , Lebbé, Céleste, Prof , Ferraresi, Virginia, MD , Smylie, Michael, MD , Weber, Jeffrey S, MD , Maio, Michele, MD , Konto, Cyril, MD , Hoos, Axel, MD , de Pril, Veerle, MSc , Gurunath, Ravichandra Karra, MD , de Schaetzen, Gaetan, PhD , Suciu, Stefan, PhD and Testori, Alessandro, MD
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background Ipilimumab is an approved treatment for patients with advanced melanoma. We aimed to assess ipilimumab as adjuvant therapy for patients with completely resected stage III melanoma at high risk of recurrence. Methods We did a double-blind, phase 3 trial in patients with stage III cutaneous melanoma (excluding lymph node metastasis...
Alternative Titles
Full title
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
Authors, Artists and Contributors
Author / Creator
Chiarion-Sileni, Vanna, MD
Grob, Jean-Jacques, Prof
Dummer, Reinhard, Prof
Wolchok, Jedd D, MD
Schmidt, Henrik, MD
Hamid, Omid, MD
Robert, Caroline, Prof
Ascierto, Paolo A, Prof
Richards, Jon M, MD
Lebbé, Céleste, Prof
Ferraresi, Virginia, MD
Smylie, Michael, MD
Weber, Jeffrey S, MD
Maio, Michele, MD
Konto, Cyril, MD
Hoos, Axel, MD
de Pril, Veerle, MSc
Gurunath, Ravichandra Karra, MD
de Schaetzen, Gaetan, PhD
Suciu, Stefan, PhD
Testori, Alessandro, MD
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1751230533
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751230533
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(15)70122-1
